Health equity in the implementation of genomics and precision medicine: A public health imperative.

Recent reviews have emphasized the need for a health equity agenda in genomics research. Crucial public health activities also include engaging communities, building coalitions, improving genetic health literacy, and building a diverse workforce.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 To ensure that genomic discoveries can lead to improved health outcomes for all segments of the population, a health equity agenda needs to go beyond research studies.
• 2 Advances in genomics and precision medicine have led to an increasing number of evidence-based applications that can reduce morbidity and mortality for millions of people (tier 1).
• 3 Studies have shown lower implementation rates for selected diseases with tier 1 applications (familial hypercholesterolemia, Lynch syndrome, hereditary breast and ovarian cancer) among racial and ethnic minority groups, rural communities, uninsured or underinsured people, and those with lower education and income.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: